Abstract:Depression is a prevalent mental illness, affecting a significant portion of the global population. Recent research has highlighted the crucial role of the gut microbiota in both metabolic and central nervous health. By reviewing literature from various databases, including Pubmed, Science Direct, Web of Science, and Scopus, spanning the years 2005–2023, a comprehensive search was conducted using keywords such as "Depression" and "Gut Microbiota". The gut microbiota acts as a "second brain" in humans and can communicate bidirectionally with the brain through the Brain-gut-microbiota axis pathway. This communication involves the immune and nervous systems. However, there are challenges in detecting and treating depression effectively. To address these limitations, researchers have been exploring the relationship between gut microbiota and depression. Studies have shown that gut microbial metabolites, such as lipopolysaccharides and short-chain fatty acids, can induce pro-inflammatory cytokines that contribute to neuroinflammation and increase the risk of depression. The kynurenine pathway, triggered by gut microbial metabolites, has also been associated with neuroinflammation. Thus, investigating these microbial metabolites can provide insights into depression treatment. This review focuses on analyzing the connection between gut microbial metabolites, inflammation, and depression. It explores novel mechanisms contributing to depression, specifically focusing on the mediation of inflammation through the release of pro-inflammatory cytokines. The objective is to provide valuable insights into the mechanisms underlying depression and to propose potential treatments.

Progress in the Application of Intestinal Flora in the Treatment of Depression

Advances in the study on brain-gut axis mechanism of common mental disorders and clinical intervention

Research progress on intestinal flora and depression

Review of research progress on intestinal microbiota based on metabolism and inflammation for depression

Current landscape of fecal microbiota transplantation in treating depression

The Microbiota–Gut–Brain Axis in Depression: The Potential Pathophysiological Mechanisms and Microbiota Combined Antidepression Effect

Depression-associated gut microbes, metabolites and clinical trials

Gut-to-brain axis provides novel therapeutic targets for depression

Gut microbiota and its metabolites in depression: from pathogenesis to treatment

Research Progress on Mechanisms of Modulating Gut Microbiota to Improve Symptoms of Major Depressive Disorder

Can Gut Flora Changes Be New Biomarkers for Depression?

Systems biology approaches to identify potential targets and inhibitors of the intestinal microbiota to treat depression

Gut microbiota-derived short-chain fatty acids and depression: deep insight into biological mechanisms and potential applications

Immunoregulatory role of the gut microbiota in inflammatory depression

Probiotics for the treatment of depression and its comorbidities: A systemic review

Mood and Microbes: a Comprehensive Review of Intestinal Microbiota’s Impact on Depression

Baseline gut microbiota profiles affect treatment response in patients with depression

Brain Neurotransmitter Modulation by Gut Microbiota in Anxiety and Depression

The intervention of unique plant polysaccharides - Dietary fiber on depression from the gut-brain axis

Prebiotics for depression: how does the gut microbiota play a role?

Human Gut Microbiota for Diagnosis and Treatment of Depression